JNJ looks to acquire trauma surgery equipment company

By
A A A

Johnson & Johnson ( JNJ ) is reportedly nearing an acquisition of a Swiss manufacturer of trauma surgery equipment, which one knowledgeable source said represents the company's "gaping hole."

The Wall Street Journal reports the acquisition for Synthes (SYST) would run about $20 billion, which would the biggest acquisition ever. The purchase would revive JNJ's medical device interests, which - like other companies' - has slumped in recent years because of the economic recession.

"It's the gaping hole in [JNJ's] orthopedic portfolio, so Synthes really is a good match for them," an unnamed source described as familiar with the industry told the publication. Synthes "pretty much built the trauma market."

Acquisition discussions between the two companies are tenuous and no time frame has been set, according to unnamed sources cited by the publication.

Orthopedic devices represent a $28.3 billion market and the company with headquarters in Switzerland and the U.S. generates almost half of the plates and screws used to repair broken bones. Dupuy, a JNJ unit, sells those type of plates and screws but not on a scale anywhere near Synthes or two other rivals.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Personal Finance , Business

Referenced Stocks: JNJ

NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

Stocks

Referenced

80%

Most Active by Volume

61,354,178
  • $10.59 ▲ 13.26%
57,732,182
  • $16.27 ▲ 1.12%
51,991,548
  • $103.30 ▲ 0.78%
48,129,834
  • $20.65 ▲ 5.52%
41,623,916
  • $12.63 ▲ 8.13%
34,295,241
  • $76.68 ▲ 2.49%
31,519,079
  • $34.57 ▼ 1.00%
28,847,879
  • $3.64 ▲ 0.28%
As of 9/2/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com